Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · Clinical Gastroenterology and Hepatology · 2006 · 907 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

William G Dixon, K. Watson, Mark Lunt et al. · Arthritis & Rheumatism · 2006 · 754 citations

Medicine, Infectious Diseases, Internal Medicine +15

Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy

Jean‐Frédéric Colombel, Edward V. Loftus, William J. Tremaine et al. · The American Journal of Gastroenterology · 2004 · 383 citations

Medicine, Perioperative Medicine, Surgery +15